Perrigo Ordinary Shares reported $4.85B in Equity Capital and Reserves for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Bayer BAYN:GR € 38019M 582M
Bristol Myers Squibb BMY:US $ 32600M 1020M
Catalent CTLT:US $ 4632M 151M
Coherus Biosciences CHRS:US $ -22.63M 35.19M
Corcept Therapeutics CORT:US $ 442.33M 34.52M
Eli Lilly And LLY:US $ 8544.7M 786.1M
Endo International Ordinary Shares ENDP:US $ -3198.07M 1887.07M
Horizon Pharma HZNP:US $ 4945.53M 127.7M
JAZZ PHA JAZZ:US $ 3200.78M 407.71M
Lannett LCI:US $ -159.31M 33.15M
Pacira Pharmaceuticals PCRX:US $ 756.64M 47.06M
Perrigo Ordinary Shares PRGO:US $ 4849.8M 254.7M
Phibro Animal Health PAHC:US $ 266.94M 27.65M
Prestige Brands PBH:US $ 1584.74M 7.13M
Supernus Pharmaceuticals SUPN:US $ 841.43M 12.99M
Teva Pharmaceutical TEVA:IT 9.04B 307M
Xeris Pharmaceuticals Inc XERS:US $ 73.94M 22.51M
Zoetis ZTS:US $ 4580M 78M